Brief: Avita Medical Inc Says Submits FDA PMA Application To Expand Indication To Vitiligo

AVITA Medical

19/12/2022 01:07

Dec 19 (Reuters) - AVITA Medical Inc  RCEL.O :
    * SUBMITS FDA PMA APPLICATION TO EXPAND INDICATION TO
VITILIGO
    * ANTICIPATE  FULL LAUNCH OF THIS TREATMENT OPTION IN
JANUARY 2025
    * APPLICATION, IF APPROVED, WILL EXPAND THE INDICATION OF 
RECELL
TO INCLUDE THE TREATMENT OF STABLE VITILIGO

Source text for Eikon:  ID:nASX4c2txQ 
Further company coverage:  RCEL.O 
 ((Reuters.Briefs@thomsonreuters.com;))